Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 125 points (-0.7%) at 16,959 as of Friday, July 25, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 982 issues advancing vs. 1,968 declining with 163 unchanged. The Health Services industry currently sits down 0.4% versus the S&P 500, which is down 0.5%. On the negative front, top decliners within the industry include WellCare Health Plans ( WCG), down 20.3%, Centene ( CNC), down 6.5%, Intuitive Surgical ( ISRG), down 1.8%, Boston Scientific ( BSX), down 1.5% and UnitedHealth Group ( UNH), down 1.2%. TheStreet would like to highlight 3 stocks pushing the industry lower today: 3. Baxter International ( BAX) is one of the companies pushing the Health Services industry lower today. As of noon trading, Baxter International is down $0.49 (-0.6%) to $76.51 on light volume. Thus far, 729,321 shares of Baxter International exchanged hands as compared to its average daily volume of 2.5 million shares. The stock has ranged in price between $76.22-$77.17 after having opened the day at $77.07 as compared to the previous trading day's close of $77.00. Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney diseases, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $41.7 billion and is part of the health care sector. Shares are up 10.7% year-to-date as of the close of trading on Thursday. Currently there are 4 analysts that rate Baxter International a buy, no analysts rate it a sell, and 10 rate it a hold. TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Baxter International Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.